{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:58:06Z","timestamp":1792112286553,"version":"4.4.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s40618-018-0884-2","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T13:39:14Z","timestamp":1525441154000},"page":"849-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":195,"title":["Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies"],"prefix":"10.1007","volume":"41","author":[{"given":"F.","family":"Pacini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Basolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bellantone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Elisei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Frasoldati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fugazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. P.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Papini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pellegriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pezzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pontecorvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Seregni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"884_CR1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020","author":"BR Haugen","year":"2015","unstructured":"Haugen BR, Alexander EK, Bible KC et al (2015) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. \n                    https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"3","key":"884_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000354537","volume":"2","author":"L Leenhardt","year":"2013","unstructured":"Leenhardt L, Erdogan MF, Hegedus L, Mandel SJ, Paschke R, Rago T et al (2013) 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J. 2(3):147\u2013159","journal-title":"Eur Thyroid J."},{"issue":"6","key":"884_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40618-014-0062-0","volume":"37","author":"F Nardi","year":"2014","unstructured":"Nardi F, Basolo F, Crescenzi A, Fadda G, Frasoldati A, Orlandi F, Palombini L, Papini E, Zini M, Pontecorvi A, Vitti P (2014) Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Investig 37(6):593\u2013599. \n                    https:\/\/doi.org\/10.1007\/s40618-014-0062-0","journal-title":"J Endocrinol Investig"},{"key":"884_CR4","volume-title":"The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes","year":"2010","unstructured":"Ali SZ, Cibas ES (eds) (2010) The Bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes. Springer, New York"},{"issue":"Suppl 1","key":"884_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.12515","volume":"81","author":"P Perros","year":"2014","unstructured":"Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, Gilbert J, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold K, Taylor J, Thakker RV, Watkinson J, Williams GR, British Thyroid Association (2014) Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 81(Suppl 1):1\u2013122","journal-title":"Clin Endocrinol (Oxf)"},{"key":"884_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/thy.2014.0096","volume":"25","author":"MW Yeh","year":"2015","unstructured":"Yeh MW, Bauer AJ, Bernet VA et al (2015) American thyroid association statement on preoperative imaging for thyroid cancer surgery. Thyroid 25:3\u201313","journal-title":"Thyroid"},{"issue":"8","key":"884_CR7","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.ejrad.2011.04.028","volume":"81","author":"LM Wu","year":"2012","unstructured":"Wu LM, Gu HY, Qu XH, Zheng J, Zhang W, Yin Y, Xu JR (2012) The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: a meta-analysis. Eur J Radiol 81(8):1798\u20131805","journal-title":"Eur J Radiol"},{"issue":"1","key":"884_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/thy.2014.0098","volume":"25","author":"RP Tufano","year":"2015","unstructured":"Tufano RP, Clayman G, Heller KS, Inabnet WB, Kebebew E, Shaha A, Steward DL, Tuttle RM (2015) American thyroid association surgical affairs committee writing task force management of recurrent\/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid 25(1):15\u201327","journal-title":"Thyroid"},{"key":"884_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/SLA.0b013e31814697d9","volume":"246","author":"KY Bilimoria","year":"2007","unstructured":"Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375\u2013381","journal-title":"Ann Surg"},{"key":"884_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00268-013-2224-1","volume":"38","author":"K Matsuzu","year":"2014","unstructured":"Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K (2014) Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg 38:68\u201379","journal-title":"World J Surg"},{"key":"884_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","volume":"260","author":"MA Adam","year":"2014","unstructured":"Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260:601\u2013605","journal-title":"Ann Surg"},{"issue":"1","key":"884_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","volume":"4","author":"Y Ito","year":"2010","unstructured":"Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 4(1):28","journal-title":"World J Surg"},{"key":"884_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","volume":"2","author":"YE Nikiforov","year":"2016","unstructured":"Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nos\u00e9 V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA (2016) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2:1023\u20131029","journal-title":"JAMA Oncol"},{"key":"884_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00268-012-1484-5","volume":"36","author":"G Glockzin","year":"2012","unstructured":"Glockzin G, Hornung M, Kienle K et al (2012) Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer. World J Surg 36:1168\u20131173","journal-title":"World J Surg"},{"key":"884_CR15","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00268-013-2089-3","volume":"37","author":"DM Hartl","year":"2013","unstructured":"Hartl DM, Mamelle E, Borget I, Leboulleux S, Mirghani H, Schlumberger M (2013) Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg 37:1951\u20131958","journal-title":"World J Surg"},{"key":"884_CR16","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1210\/jc.2014-3825","volume":"100","author":"D Viola","year":"2015","unstructured":"Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, Seccia V, Sensi E, Romei C, Piaggi P, Torregrossa L, Sellari-Franceschini S, Basolo F, Vitti P, Elisei R, Miccoli P (2015) Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 100:1316\u20131324","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR17","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00268-015-3108-3","volume":"39","author":"N Qu","year":"2015","unstructured":"Qu N, Zhang L, Ji QH, Chen JY, Zhu YX, Cao YM, Shen Q (2015) Risk factors for central compartment lymph node metastasis in papillary thyroid microcarcinoma: a meta-analysis. World J Surg 39:2459\u20132470","journal-title":"World J Surg"},{"key":"884_CR18","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1245\/s10434-015-4383-9","volume":"22","author":"M Raffaelli","year":"2015","unstructured":"Raffaelli M, De Crea C, Sessa L, Fadda G, Bellantone C, Lombardi CP (2015) Ipsilateral central neck dissection plus frozen section examination versus prophylactic bilateral central neck dissection in cN0 papillary thyroid carcinoma. Ann Surg Oncol 22:2032\u20132308","journal-title":"Ann Surg Oncol"},{"key":"884_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2559.2004.01729.x","volume":"44","author":"P Collini","year":"2004","unstructured":"Collini P, Sampietro G, Pilotti S (2004) Extensive vascular invasion is a marker of risk of relapse in encapsulated non-H\u00fcrthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology 44:35\u201339","journal-title":"Histopathology"},{"key":"884_CR20","unstructured":"Mahul B, Amin SE, Greene FL, Schilsky RL, Byrd DR, Gaspar LE, Washington MK, Gershenwald JE, Compton CC, Hess KR (2017) In: Brierley JD, Gospodarowicz MK, Wittekind C (eds) 2016 AJCC 8th Edition Cancer Staging Manual. Springer International Publishing AG, Cham, Switzerland.Edition). Wiley Blackwell, Oxford"},{"key":"884_CR21","first-page":"144A","volume":"25","author":"I Ganly","year":"2012","unstructured":"Ganly I, Ibrahimpasic T, Rivera M et al (2012) Prognostic implication of papillary thyroid carcinoma with tall cell features. Mod Pathol 25:144A","journal-title":"Mod Pathol"},{"key":"884_CR22","first-page":"143","volume":"25","author":"MS Dettmer","year":"2012","unstructured":"Dettmer MS, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A (2012) Tall cell variant of papillary thyroid carcinoma- how many tall cells are needed? Mod Pathol 25:143","journal-title":"Mod Pathol"},{"key":"884_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/thy.2009.0352","volume":"20","author":"LG Morris","year":"2010","unstructured":"Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I (2010) Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Thyroid 20:153\u2013158","journal-title":"Thyroid"},{"key":"884_CR24","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1089\/thy.2013.0573","volume":"24","author":"CC Lubitz","year":"2014","unstructured":"Lubitz CC, Economopoulos KP, Pawlak AC, Lynch K, Dias-Santagata D, Faquin WC, Sadow PM (2014) Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid 24:958\u2013965","journal-title":"Thyroid"},{"key":"884_CR25","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1097\/00000478-200112000-00002","volume":"25","author":"YE Nikiforov","year":"2001","unstructured":"Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV (2001) Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Sur Pathol 25:1478\u20131484","journal-title":"Am J Sur Pathol"},{"key":"884_CR26","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","volume":"31","author":"M Volante","year":"2007","unstructured":"Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256\u20131264","journal-title":"Am J Surg Pathol"},{"key":"884_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/modpathol.2010.117","volume":"23","author":"S Asioli","year":"2010","unstructured":"Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, Bussolati G, Lloyd RV (2010) Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol 23:1269\u20131278","journal-title":"Mod Pathol"},{"key":"884_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/thy.2010.0331","volume":"21","author":"C Regalbuto","year":"2011","unstructured":"Regalbuto C, Malandrino P, Tumminia A, Le Moli R, Vigneri R, Pezzino V (2011) A diffuse sclerosing variant of papillary th thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid 21:383\u2013389","journal-title":"Thyroid"},{"key":"884_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1245\/ASO.2006.03.062","volume":"13","author":"AK Lam","year":"2006","unstructured":"Lam AK, Lo CY (2006) Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol 13:176\u2013181","journal-title":"Ann Surg Oncol"},{"key":"884_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0039-6060(03)00384-2","volume":"135","author":"I Sugitani","year":"2004","unstructured":"Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004) A novel classification system for patients with PTC: addition of the new variables of large (3\u00a0cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139\u2013148","journal-title":"Surgery"},{"key":"884_CR31","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1210\/jc.2014-3882","volume":"100","author":"L Lamartina","year":"2015","unstructured":"Lamartina L, Durante C et al (2015) Low risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature. J Clin Endocrinol Metab 100:1748\u20131761","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40618-015-0375-7","volume":"39","author":"F Pacini","year":"2016","unstructured":"Pacini F et al (2016) Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology. J Endocrinol Investig 39:341\u2013347","journal-title":"J Endocrinol Investig"},{"key":"884_CR33","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s40618-016-0503-z","volume":"39","author":"MG Castagna","year":"2016","unstructured":"Castagna MG et al (2016) Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients. J Endocrinol Invest 39:1087\u20131094","journal-title":"J Endocrinol Invest"},{"key":"884_CR34","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1210\/jc.2014-4332","volume":"100","author":"E Ruel","year":"2015","unstructured":"Ruel E, Thomas S et al (2015) Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab 100:1529\u20131536","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR35","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1210\/jc.2005-1651","volume":"91","author":"F Pacini","year":"2006","unstructured":"Pacini F, Ladenson PW et al (2006) Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 91:926\u2013932","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR36","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","volume":"366","author":"M Schlumberger","year":"2012","unstructured":"Schlumberger M, Catargi B et al (2012) Strategies of radioiodine ablation in patients with low-risk thyoid cancer. NEJM 366:1663\u20131673","journal-title":"NEJM"},{"key":"884_CR37","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","volume":"366","author":"U Mallick","year":"2012","unstructured":"Mallick U, Harmer C et al (2012) Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. NEJM 366:1674\u20131685","journal-title":"NEJM"},{"key":"884_CR38","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1210\/jc.2012-4137","volume":"98","author":"E Molinaro","year":"2013","unstructured":"Molinaro E, Giani C et al (2013) Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity 131I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up. J Clin Endocrinol Metab 98:2693\u20132700","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR39","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1210\/jc.2014-1631","volume":"99","author":"FA Verburg","year":"2014","unstructured":"Verburg FA, Mader U et al (2014) Long term survival in DTC is worse after low-activity initial post-surgical I-131 therapy in both high and low risk patients. J Clin Endocrinol Metab 99:4487\u20134496","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EJE-12-0954","volume":"169","author":"MG Castagna","year":"2013","unstructured":"Castagna MG, Cevenini G et al (2013) Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients. Eur J Endocrinol 169:23\u201329","journal-title":"Eur J Endocrinol"},{"key":"884_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1210\/jc.2009-1624","volume":"95","author":"HP Tala Jury","year":"2010","unstructured":"Tala Jury HP, Castagna MG, Fioravanti C, Cipri C, Brianzoni E, Pacini F (2010) Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients. J Clin Endocrinol Metab 95:230\u2013237","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"884_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/thy.2010.0403","volume":"21","author":"JC Sisson","year":"2011","unstructured":"American Thyroid Association Taskforce On Radioiodine Safety, Sisson JC, Freitas J, McDougall IR, Dauer LT, Hurley JR, Brierley JD, Edinboro CH, Rosenthal D, Thomas MJ, Wexler JA, Asamoah E, Avram AM, Milas M, Greenlee C (2011) Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid 21(4):335\u2013346","journal-title":"Thyroid"},{"issue":"2","key":"884_CR43","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1016\/j.icrp.2004.08.001","volume":"34","author":"International Commission on Radiological Protection","year":"2004","unstructured":"International Commission on Radiological Protection (2004) Release of patients after therapy with unsealed radionuclides. Ann ICRP 34(2):v\u2013vi, 1\u201379","journal-title":"Ann ICRP"},{"key":"884_CR44","unstructured":"Raccomandazioni per la dimissione dei pazienti a seguito di terapia medico nucleare con 131I. \n                    http:\/\/www.fisicamedica.it\/2014_07_01_Raccomandazioni_dimissione_pazienti_131I.pdf"},{"key":"884_CR45","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1210\/jc.2010-2708","volume":"96","author":"M Brassard","year":"2011","unstructured":"Brassard M, Borget I, Edet-Sanson A, Giraudet AL, Mundler O, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Toubert ME, Torlontano M, Benhamou E, Schlumberger M, THYRDIAG Working Group (2011) Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab 2011 96:1352\u20131359","journal-title":"J Clin Endocrinol Metab 2011"},{"key":"884_CR46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/thy.2010.0355","volume":"21","author":"A Miyauchi","year":"2011","unstructured":"Miyauchi A, Kudo T, Miya A, Kobayashi K, Ito Y, Takamura Y, Higashiyama T, Fukushima M, Kihara M, Inoue H, Tomoda C, Yabuta T, Masuoka H (2011) Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 21:707\u2013716","journal-title":"Thyroid"},{"key":"884_CR47","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1210\/jc.2012-1123","volume":"97","author":"C Durante","year":"2012","unstructured":"Durante C, Montesano T, Attard M, Torlontano M, Monzani F, Costante G, Meringolo D, Ferdeghini M, Tumino S, Lamartina L, Paciaroni A, Massa M, Giacomelli L, Ronga G, Filetti S, PTC Study Group (2012) Long-term surveillance of papillary thyroid cancer patients who do not undergo post-operative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement. J Clin Endocrinol Metab 2012 97:2748\u20132753","journal-title":"J Clin Endocrinol Metab 2012"},{"key":"884_CR48","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/jc.2012-3401","volume":"98","author":"C Durante","year":"2013","unstructured":"Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, Costante G, Meringolo D, Bruno R, Trulli F, Massa M, Maniglia A, D\u2019Apollo R, Giacomelli L, Ronga G, Filetti S, PTC Study Group (2013) Papillary thyroid cancer: time course of recurrences during postsurgery surveillance. J Clin Endocrinol Metab 2013 98:636\u2013642","journal-title":"J Clin Endocrinol Metab 2013"},{"key":"884_CR49","first-page":"e219","volume":"34","author":"MG Castagna","year":"2011","unstructured":"Castagna MG, Tala Jury HP, Cipri C, Belardini V, Fioravanti C, Pasqui L, Sestini F, Theodoropoulou A, Pacini F (2011) The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma. J Endocrinol Investig 34:e219\u2013e223","journal-title":"J Endocrinol Investig"},{"key":"884_CR50","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1210\/jc.2005-1185","volume":"91","author":"M Torlontano","year":"2006","unstructured":"Torlontano M, Crocetti U, Augello G, D\u2019Aloiso L, Bonfitto N, Varraso A, Dicembrino F, Modoni S, Frusciante V, Di GA, Bruno R, Filetti S, Trischitta V (2006) Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 2006 91:60\u201363","journal-title":"J Clin Endocrinol Metab 2006"},{"key":"884_CR51","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"RM Tuttle","year":"2010","unstructured":"Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A (2010) Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 20:1341\u20131349","journal-title":"Thyroid"},{"key":"884_CR52","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1089\/thy.2011.0232","volume":"21","author":"F Vaisman","year":"2011","unstructured":"Vaisman F, Tala H, Grewal R, Tuttle RM (2011) In differentiated thyroid cancer, an incomplete structural reponse to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21:1317\u20131322","journal-title":"Thyroid"},{"key":"884_CR53","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892\u20132899","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR54","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1210\/jc.2005-1534","volume":"91","author":"RJ Robbins","year":"2006","unstructured":"Robbins RJ, Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HW, Tuttle RM, Drucker W, Larson SM (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-d-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91:498\u2013505","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR55","doi-asserted-by":"publisher","first-page":"398194","DOI":"10.1155\/2013\/398194","volume":"2013","author":"F Vaisman","year":"2013","unstructured":"Vaisman F, Momesso D, Bulzico DA, Pessoa CH, da Cruz MD, Dias F, Corbo R, Vaisman M, Tuttle RM (2013) Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J Thyroid Res 2013:398194. \n                    https:\/\/doi.org\/10.1155\/2013\/398194","journal-title":"J Thyroid Res"},{"issue":"7","key":"884_CR56","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1210\/jc.2015-4290","volume":"101","author":"DP Momesso","year":"2016","unstructured":"Momesso DP, Vaisman F, Yang SP, Bulzico DA, Corbo R, Vaisman M, Tuttle RM (2016) Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. J Clin Endocrinol Metab 101(7):2692\u20132700","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR57","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1007\/s00259-010-1565-3","volume":"37","author":"LS Freudenberg","year":"2010","unstructured":"Freudenberg LS, Jentzen W, Petrich T, Fr\u00f6mke C, Marlowe RJ, Heusner T, Brandau W, Knapp WH, Bockisch A (2010) Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET\/CT dosimetric comparisons. Eur J Nucl Med Mol Imaging 37:2267\u20132276","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"884_CR58","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2265.2006.02626.x","volume":"65","author":"C Potzi","year":"2006","unstructured":"Potzi C, Moameni A, Karanikas G, Preitfellner J, Becherer A, Pirich C, Dudczak R (2006) Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients. Clin Endocrinol (Oxf) 2006 65:519\u2013523","journal-title":"Clin Endocrinol (Oxf) 2006"},{"key":"884_CR59","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00259-014-2737-3","volume":"41","author":"D Rani","year":"2014","unstructured":"Rani D, Kaisar S, Awasare S, Kamaldeep P, Abhyankar A, Basu S (2014) Examining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol. Eur J Nucl Med Mol Imaging 41:1767\u20131780","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"884_CR60","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1210\/jc.2011-0305","volume":"96","author":"H Tala","year":"2011","unstructured":"Tala H, Robbins R, Fagin JA, Larson SM, Tuttle RM (2011) Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH. J Clin Endocrinol Metab 96:2105\u20132111","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR61","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/105072502753522356","volume":"12","author":"D Nostrand Van","year":"2002","unstructured":"Van Nostrand D, Atkins F, Yeganeh F, Acio E, Bursaw R, Wartofsky L (2002) Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid 12:121\u2013134","journal-title":"Thyroid"},{"key":"884_CR62","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2967\/jnumed.116.179606","volume":"58","author":"D Deandreis","year":"2017","unstructured":"Deandreis D, Rubino C, Tala H, Leboulleux S, Terroir M, Baudin E, Larson S, Fagin JA, Schlumberger M, Tuttle RM (2017) Comparison of empiric versus whole-body\/-blood clearance dosimetry-based approach to radioactive iodine treatment in patients with metastases from differentiated thyroid cancer. J Nucl Med 58:717\u2013722","journal-title":"J Nucl Med"},{"key":"884_CR63","first-page":"1888","volume":"28","author":"F Pacini","year":"1987","unstructured":"Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C, Pinchera A (1987) Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 28:1888\u20131891","journal-title":"J Nucl Med"},{"key":"884_CR64","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1089\/thy.2011.0522","volume":"22","author":"RP Padovani","year":"2012","unstructured":"Padovani RP, Robenshtok E, Brokinn M, Tuttle RM (2012) Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer. Thyroid 22:778\u2013783","journal-title":"Thyroid"},{"key":"884_CR65","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ctrv.2015.09.001","volume":"41","author":"SC Clement","year":"2015","unstructured":"Clement SC, Peeters RP, Ronckers CM et al (2015) Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma\u2014a systematic review. Cancer Treat Rev 41:925\u2013934","journal-title":"Cancer Treat Rev"},{"key":"884_CR66","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1177\/0194599813479777","volume":"148","author":"IF Dingle","year":"2013","unstructured":"Dingle IF, Mishoe AE, Nguyen SA et al (2013) Salivary morbidity and quality of life following radioactive iodine for well-differentiated thyroid cancer. Otolaryngol Head Neck Surg 148:746\u2013752","journal-title":"Otolaryngol Head Neck Surg"},{"key":"884_CR67","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/cen.12514","volume":"82","author":"D Canale","year":"2015","unstructured":"Canale D, Ceccarelli C, Caglieresi C et al (2015) Effects of radioiodine treatment for differentiated thyroid cancer on testis function. Clin Endocrinol (Oxf) 82:295\u2013299","journal-title":"Clin Endocrinol (Oxf)"},{"key":"884_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/thy.2014.0343","volume":"25","author":"JX Wu","year":"2015","unstructured":"Wu JX, Young S, Ro K et al (2015) Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well differentiated thyroid cancer. Thyroid 25:133\u2013138","journal-title":"Thyroid"},{"key":"884_CR69","first-page":"220","volume":"23","author":"AR Khang","year":"2015","unstructured":"Khang AR, Cho SW, Choi HS et al (2015) The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131) I dose over 37 GBq. Clin Endocrinol (Oxf) 23:220\u2013227","journal-title":"Clin Endocrinol (Oxf)"},{"key":"884_CR70","first-page":"1366","volume":"45","author":"G Sgouros","year":"2004","unstructured":"Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, Robbins RJ, Larson SM (2004) Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 45:1366\u20131372","journal-title":"J Nucl Med"},{"key":"884_CR71","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","volume":"384","author":"MS Brose","year":"2014","unstructured":"Brose MS, Nutting CM, Jarzab B et al (2014) Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 384:319\u2013328","journal-title":"Lancet"},{"key":"884_CR72","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1406470","volume":"372","author":"M Schlumberger","year":"2015","unstructured":"Schlumberger M, Tahara M, Wirth LJ et al (2015) Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 372:621\u2013630","journal-title":"N Engl J Med"},{"issue":"4","key":"884_CR73","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.surg.2010.07.019","volume":"148","author":"SS Abadin","year":"2010","unstructured":"Abadin SS, Kaplan EL, Angelos P (2010) Malpractice litigation after thyroid surgery: the role of recurrent laryngeal nerve injuries, 1989\u20132009. Surgery 148(4):718\u2013722","journal-title":"Surgery"},{"key":"884_CR74","first-page":"298","volume":"11","author":"A Polistena","year":"2016","unstructured":"Polistena A, Di Lorenzo P, Sanguinetti A, Buccelli C, Conzo G, Conti A, Niola M, Avenia N (2016) Medicolegal implications of surgical errors and complications in neck surgery: a review based on the Italian current legislation. Open Med 2016 11:298\u2013306","journal-title":"Open Med 2016"},{"key":"884_CR75","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1089\/thy.2012.0043","volume":"22","author":"GW Randolph","year":"2012","unstructured":"Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, Tufano RP, Tuttle RM (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144\u20131152","journal-title":"Thyroid"},{"key":"884_CR76","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1210\/jc.2005-0285","volume":"90","author":"S Leboulleux","year":"2005","unstructured":"Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and\/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723\u20135729","journal-title":"J Clin Endocrinol Metab"},{"key":"884_CR77","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/thy.2013.0027","volume":"23","author":"M Lango","year":"2013","unstructured":"Lango M, Flieder D, Arrangoiz R, Veloski C, Yu JQ, Li T, Burtness B, Mehra R, Galloway T, Ridge JA (2013) Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid 23:1099\u20131105","journal-title":"Thyroid"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0884-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0884-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0884-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T23:25:07Z","timestamp":1556925907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0884-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["884"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0884-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"27 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study complies with ethical standard of research. It does not involve data or treatment of human being nor animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}